|
|
|
|
|
by inglor_cz
718 days ago
|
|
At the very least, FDA should allow use of medications that were approved in Japan or the EU. Requiring separate US clinical trials is an unnecessary burden for the manufacturer, and will likely result in higher prices or unavailability of some medications. Even in programming we frown upon "reinventing the wheel". This is reinventing the wheel with a fantastic price tag. |
|